Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Biomarker Hunt Finds Potential With ctDNA in Melanoma

Jessica Hergert
Published: Thursday, Jan 16, 2020

David Polsky, MD, PhD, professor of dermatology at NYU Langone Health

David Polsky, MD, PhD

As the search for blood- and tissue-based biomarkers continues in localized and metastatic melanoma, circulating tumor DNA (ctDNA) has emerged as a potential candidate for patients with BRAF-mutated disease, said David Polsky, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication